Characteristic n (%) or median (IQR) | Total Population n = 283 | Died in Hospital n = 36 | Alive n = 247 | P-value |
---|---|---|---|---|
Patient Characteristics | ||||
Age, years | 41 (30–57) | 46 (33–63) | 40 (29–56) | 0.14 |
Sex, male | 153 (54%) | 24 (67%) | 129 (52%) | 0.10 |
Comorbidities | ||||
HIV/AIDS | 4 (1%) | 0 | 4 (62%) | 1.0 |
Injection drug use | 164 (58%) | 24 (67%) | 140 (57%) | 0.26 |
Hepatitis C virus | 110 (39%) | 7 (19%) | 103 (42%) | 0.01 |
Diabetes mellitus | 40 (14%) | 5 (14%) | 35 (14%) | 0.96 |
Heart failure | 64 (23%) | 8 (22%) | 56 (23%) | 1.0 |
Atrial fibrillation | 31 (110%) | 7 (19%) | 24 (10%) | 0.09 |
Hemodialysis | 15 (5%) | 0 | 15 (6%) | 0.23 |
Acute renal failure/hemodialysis | 99 (35%) | 27 (75%) | 72 (29%) | < 0.001 |
Septic shock | 93 (33%) | 28 (78%) | 65 (26%) | < 0.001 |
Troponin obtained | 212 (75%) | 33 (92%) | 179 (73%) | 0.01 |
Infection Characteristics and Outcomes | ||||
Septic Emboli | 151 (54%) | 27 (75%) | 124 (50%) | 0.005 |
Left-sided IE | 86 (30%) | 18 (50%) | 68 (28%) | 0.01 |
IE Valve Surgery | 44 (16%) | 0 | 44 (18%) | 0.01 |
MRSA IE | 91 (32%) | 16 (44%) | 75 (30%) | 0.09 |
LAMA | 24 (9%) | 0 | 24 (10%) | 0.05 |